Article

Research points to prostate cancer biomarker

A recently published study supports the adoption of a new biomarker to measure the aggressiveness of primary prostate tumors.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Man talking with a doctor | Image Credit: © Pcess609 - stock.adobe.com
Tool predicts prostate cancer outcomes using patient-reported data
Looking Ahead: the future of NMIBC treatment
Looking Ahead: the future of NMIBC treatment
Look ahead at future trial updates
Look ahead at future trial updates
Related Content
Vaginal estrogen tablets not linked with increased risk of recurrent ischemic stroke
August 25th 2025

Vaginal estrogen tablets not linked with increased risk of recurrent ischemic stroke

Hannah Clarke
First Assist: The Historical Context of Advanced Kidney Cancer, with Eric A. Singer, MD
August 25th 2025

First Assist: The Historical Context of Advanced Kidney Cancer, with Eric A. Singer, MD

Taylor Goodstein, MD
Novel alpha particle therapy holds promise in prostate, bladder cancer
August 25th 2025

Novel alpha particle therapy holds promise in prostate, bladder cancer

Robert B. Den, MD
Introducing First Assist: GU Oncology Unpacked, with Taylor Goodstein, MD!
August 25th 2025

Introducing First Assist: GU Oncology Unpacked, with Taylor Goodstein, MD!

Taylor Goodstein, MD
Continuing an ARPI with [177Lu]Lu-PSMA-617 may not provide additional benefit in mCRPC
August 25th 2025

Continuing an ARPI with [177Lu]Lu-PSMA-617 may not provide additional benefit in mCRPC

Hannah Clarke
waiting area for patients with doctor appointments in modern healthcare clinic in private practice hospital | Image Credit: © sirisakboakaew - stock.adobe.com
August 25th 2025

Oral sulopenem for uncomplicated urinary tract infection launches on US market

Hannah Clarke
© 2025 MJH Life Sciences

All rights reserved.